title: Use of eltrombopag for the treatment of thrombocytopenia in hypoplastic myelodysplastic syndrome.
authors.affiliation: Department of Hematology/Oncology, St Joseph's Regional Medical Center, Seton Hall University School of Health and Medical Sciences, Paterson, NJ, USA.
authors.forename: Dron
authors.initials: D
authors.lastname: Gauchan
authors.forename: Hamid
authors.initials: H
authors.lastname: Shaaban
authors.forename: David
authors.initials: D
authors.lastname: Gedeon
authors.forename: Michael
authors.initials: M
authors.lastname: Maroules
mesh_terms: D000369:Aged, 80 and over; D001565:Benzoates / Q000627:therapeutic use*; D001853:Bone Marrow / Q000473:pathology; D017707:Erythrocyte Transfusion; D005260:Female; D006474:Hemorrhagic Disorders / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D009190:Myelodysplastic Syndromes / Q000150:complications* / Q000628:therapy; D017713:Platelet Transfusion; D011720:Pyrazoles / Q000627:therapeutic use*; D053628:Receptors, Thrombopoietin / Q000819:agonists; D013921:Thrombocytopenia / Q000188:drug therapy* / Q000209:etiology
chemical_list: D001565:Benzoates; D006834:Hydrazines; D011720:Pyrazoles; D053628:Receptors, Thrombopoietin; C082218:MPL protein, human; C520809:eltrombopag